Mutational screening to improve the transplantation decision-making process in MDS-Reference-Cited by-同舟云学术

Mutational screening to improve the transplantation decision-making process in MDS

Published:2023-12-08 Issue:1 Volume:2023 Page:73-76
ISSN:1520-4391
Container-title:Hematology
language:en
Short-container-title:

Author:

Campagna Alessia¹,Della Porta Matteo G.¹

Affiliation:

1. Comprehensive Cancer Center and Center for Accelerating Leukemia/Lymphoma Research, IRCCS Humanitas Research Hospital, Humanitas University and Humanitas AI Center, Milan, Italy

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/hematology/article-pdf/2023/1/73/2178843/73campagna.pdf

Reference12 articles.

1. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

2. Clinical and biological implications of driver mutations in myelodysplastic syndromes;Papaemmanuil;Blood,2013

3. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes;Bernard;Nat Med,2020

4. Molecular International Prognostic Scoring System for myelodysplastic syndromes;Bernard;NEJM Evid,2022

5. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;de Witte;Blood,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes;Journal of Clinical Oncology;2024-08-20

2. Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms;Cancers;2024-04-19